Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity

ACS Chemical Biology

Volumn 7, Issue 10, 2012, Pages 1666-1676

  Paduano, Francesco ^a   Ortuso, Francesco ^a   Campiglia, Pietro ^b   Raso, Cinzia ^a   Iaccino, Enrico ^a   Gaspari, Marco ^a   Gaudio, Eugenio ^a,c   Mangone, Graziella ^a   Carotenuto, Alfonso ^d   Bilotta, Anna ^a   Narciso, Domenico ^a   Palmieri, Camillo ^a   Agosti, Valter ^a   Artese, Anna ^a   Gomez Monterrey, Isabel ^d   Sala, Marina ^b   Cuda, Giovanni ^a   Iuliano, Rodolfo ^a   Perrotti, Nicola ^a   Scala, Giuseppe ^a   Viglietto, Giuseppe ^a   Alcaro, Stefano ^a   Croce, Carlo M ^c   Novellino, Ettore ^d   Fusco, Alfredo ^e   Trapasso, Francesco ^a   more..

^a Laboratorio di Chimica Farmaceutica Computazionale Dipartimento di Scienze Farmacobiologiche Universitaà Magna Grcia di Catanzaro   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN P27; PROTEIN TYROSINE PHOSPHATASE; PTPRJ PROTEIN; UNCLASSIFIED DRUG; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PEPTIDE; PEPTIDE LIBRARY; PHOSPHOTYROSINE; PTPRJ PROTEIN, HUMAN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; HELA CELL; HUMAN; HUMAN CELL; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CHEMICAL STRUCTURE; DRUG EFFECTS; HELA CELL LINE; METABOLISM; PEPTIDE LIBRARY; PHOSPHORYLATION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HELA CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, MOLECULAR; PEPTIDE LIBRARY; PEPTIDES; PHOSPHORYLATION; PHOSPHOTYROSINE; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3;

EID: 84867752182     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb300281t     Document Type: Article

References (49)

1. Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., and Mustelin, T. (2004) Protein tyrosine phosphatases in the human genome Cell 117, 699-711
2. Ostman, A., Hellberg, C., and Boähmer, F. D. (2006) Protein-tyrosine phosphatases and cancer Nat. Rev. Cancer 6, 307-320
3. Honda, H., Inazawa, J., Nishida, J., Yazaki, Y., and Hirai, H. (1994) Molecular cloning, characterization, and chromosomal localization of a novel protein-tyrosine phosphatase, HPTP eta Blood 84, 4186-4194
4. Ostman, A., Yang, Q., and Tonks, N. K. (1994) Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density Proc. Natl. Acad. Sci. U.S.A. 91, 9680-9684
5. Keane, M. M., Lowrey, G. A., Ettenberg, S. A., Dayton, M. A., and Lipkowitz, S. (1996) The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells Cancer Res. 56, 4236-4243
6. Zhang, L., Martelli, M. L., Battaglia, C., Trapasso, F., Tramontano, D., Viglietto, G., Porcellini, A., Santoro, M., and Fusco, A. (1997) Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase Exp. Cell. Res. 235, 62-70
7. Trapasso, F., Iuliano, R., Boccia, A., Stella, A., Visconti, R., Bruni, P., Baldassarre, G., Santoro, M., Viglietto, G., and Fusco, A. (2000) Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1) Mol. Cell. Biol. 20, 9236-9246
8. Paduano, F., Dattilo, V., Narciso, D., Bilotta, A., Gaudio, E., Menniti, M., Agosti, V., Palmieri, C., Perrotti, N., Fusco, A., Trapasso, F., and Iuliano, R. (2012) Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328 FEBS J. May 7 10.1111/j.1742-4658.2012.08624.x
9. Iuliano, R., Trapasso, F., Le Pera, I., Schepis, F., Samaà, I., Clodomiro, A., Dumon, K. R., Santoro, M., Chiarotti, L., Viglietto, G., and Fusco, A. (2003) An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo Cancer Res. 63, 882-886
10. Trapasso, F., Yendamuri, S., Dumon, K. R., Iuliano, R., Cesari, R., Feig, B., Seto, R., Infante, L., Ishii, H., Vecchione, A., During, M. J., Croce, C. M., and Fusco, A. (2004) Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo Carcinogenesis 25, 2107-2114
11. Ruivenkamp, C. A., van Wezel, T., Zanon, C., Stassen, A. P., Vlcek, C., CsikoÌs, T., Klous, A. M., Tripodis, N., Perrakis, A., Boerrigter, L., Groot, P. C., Lindeman, J., Mooi, W. J., Meijjer, G. A., Scholten, G., Dauwerse, H., Paces, V., van Zandwijk, N., van Ommen, G. J., and Demant, P. (2002) Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers Nat. Genet. 31, 295-300
12. Ruivenkamp, C., Hermsen, M., Postma, C., Klous, A., Baak, J., Meijer, G., and Demant, P. (2003) LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21 Oncogene 22, 3472-3474
13. Iuliano, R., Le Pera, I., Cristofaro, C., Baudi, F., Arturi, F., Pallante, P., Martelli, M. L., Trapasso, F., Chiariotti, L., and Fusco, A. (2004) The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis Oncogene 23, 8432-8438
14. Trapasso, F., Drusco, A., Costinean, S., Alder, H., Aqeilan, R. I., Iuliano, R., Gaudio, E., Raso, C., Zanesi, N., Croce, C. M., and Fusco, A. (2006) Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis DNA Cell Biol. 25, 376-382
15. Zhu, J. W., Brdicka, T., Katsumoto, T. R., Lin, J., and Weiss, A. (2008) Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling Immunity 28, 183-196
16. Kovalenko, M., Denner, K., Sandstroäm, J., Persson, C., Gross, S., Jandt, E., Vilella, R., Boähmer, F., and Ostman, A. (2000) Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1 J. Biol. Chem. 275, 16219-16226
17. Palka, H. L., Park, M., and Tonks, N. K. (2003) Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1 J. Biol. Chem. 278, 5728-5735
18. Iervolino, A., Iuliano, R., Trapasso, F., Viglietto, G., Melillo, R. M., Carlomagno, F., Santoro, M., and Fusco, A. (2006) The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins Cancer Res. 66, 6280-6287
19. Berset, T. A., Hoier, E. F., and Hajnal, A. (2005) The C. elegans homolog of the mammalian tumor suppressor Dep-1/Scc1 inhibits EGFR signaling to regulate binary cell fate decisions Genes Dev. 19, 1328-1340
20. Hanahan, D. and Weinberg, R. A. (2000) The hallmarks of cancer Cell 100, 57-70
21. Baker, J. E., Majeti, R., Tangye, S. G., and Weiss, A. (2001) Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylation Mol. Cell. Biol. 21, 2393-2403
22. Omerovic, J., Clague, M. J., and Prior, I. A. (2010) Phosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in Ras-mutated cancer cells Biochem. J. 426, 65-72
23. Tsuboi, N., Utsunomiya, T., Roberts, R. L., Ito, H., Takahashi, K., Noda, M., and Takahashi, T. (2008) The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase Biochem. J. 413, 193-200
24. Lampugnani, G. M., Zanetti, A., Corada, M., Takahashi, T., Balconi, G., Breviario, F., Orsenigo, F., Cattelino, A., Kemler, R., Daniel, T. O., and Dejana, E. (2003) Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148 J. Cell Biol. 161, 793-804
25. Chabot, C., Spring, K., Gratton, J. P., Elchebly, M., and Royal, I. (2009) New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival Mol. Cell. Biol. 29, 241-53
26. Whiteford, J. R., Xian, X., Chaussade, C., Vanhaesebroeck, B., Nourshargh, S., and Couchman, J. R. (2011) Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148 Mol. Biol. Cell 22, 3609-24
27. Takahashi, K., Mernaugh, R. L., Friedman, D. B., Weller, R., Tsuboi, N., Yamashita, H., Quaranta, V., and Takahashi, T. (2012) Trombospondin-1 acts as a ligand for CD148 tyrosine phosphatase Proc. Natl. Acad. Sci. U.S.A. 109, 1985-90
28. Takahashi, T., Takahashi, K., Mernaugh, R. L., Tsuboi, N., Liu, H., and Daniel, T. O. (2006) A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis Blood 108, 1234-1242
29. Barry, M. A., Dower, W. J., and Johnston, S. A. (1996) Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries Nat. Med. 2, 299-305
30. Giordano, R. J., CardoÌ-Vila, M., Lahdenranta, J., Pasqualini, R., and Arap, W. (2001) Biopanning and rapid analysis of selective interactive ligands Nat. Med. 7, 1249-1253
31. Sacco, F., Tinti, M., Palma, A., Ferrari, E., Nardozza, A. P., Hooft van Huijsduijnen, R., Takahashi, T., Castagnoli, L., and Cesareni, G. (2009) Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases J. Biol. Chem. 284, 22048-22058
32. Daura, X., Gademann, K., Jaun, B., Seebach, D., van Gunsteren, W. F., and Mark, A. E. (1999) Peptide folding: When simulation meets experiment Angew. Chem. Int. 38, 236-40
33. Wuäthrich, K. (1986) NMR of Proteins and Nucleic Acids, John Wiley & Sons, Inc., New York.
34. Wu, D., Chen, A., and Johnson, C. S. (1995) An improved diffusion-ordered spectroscopy experiment incorporating bipolar-gradient pulses J. Magn. Reson. Ser. A 115, 260-264
35. Wilkins, D. K., Grimshaw, S. B., Receveur, V., Dobson, C. M., Jones, J. A., and Smith, L. J. (1999) Hydrodynamic radii of native and denatured proteins measured by pulse field gradient NMR techniques Biochemistry 38, 16424-16431
36. Mayer, M. and Meyer, B. (1999) Characterization of ligand binding by saturation transfer difference NMR spectroscopy Angew. Chem., Int. Ed. 38, 1784-1788
37. Zhang, J., Yang, P. L., and Gray, N. S. (2009) Targeting cancer with small molecule kinase inhibitors Nat. Rev. Cancer 9, 28-39
38. Gschwind, A., Fischer, O. M., and Ullrich, A. (2004) The discovery of receptor tyrosine kinases: targets for cancer therapy Nat. Rev. Cancer 4, 361-370
39. Reilly, R. M., Sandhu, J., Alvarez-Diez, T. M., Gallinger, S., Kirsh, J., and Stern, H. (1995) Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions Clin. Pharmacokinet. 28, 126-142
40. Aina, O. H., Sroka, T. C., Chen, M. L., and Lam, K. S. (2002) Therapeutic cancer targeting peptides Biopolymers 66, 184-199
41. Soärby, M., Sandstroäm, J., and Ostman, A. (2001) An extracellular ligand increases the specific activity of the receptor-like protein tyrosine phosphatase DEP-1 Oncogene 20, 5219-5224
42. Ballinger, M. D., Shyamala, V., Forrest, L. D., Deuter-Reinhard, M., Doyle, L. V., Wang, J. X., Panganiban-Lustan, L., Stratton, J. R., Apell, G., Winter, J. A., Doyle, M. V., Rosenberg, S., and Kavanaugh, W. M. (1999) Semirational design of a potent, artificial agonist of fibroblast growth factor receptors Nat. Biotechnol. 17, 1199-1204
43. Cwirla, S. E., Balasubramanian, P., Duffin, D. J., Wagstrom, C. R., Gates, C. M., Singer, S. C., Davis, A. M., Tansik, R. L., Mattheakis, L. C., Boytos, C. M., Schatz, P. J., Baccanari, D. P., Wrighton, N. C., Barrett, R. W., and Dower, W. J. (1997) Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine Science 276, 1696-1699
44. Wrighton, N. C., Farrell, F. X., Chang, R., Kashyap, A. K., Barbone, F. P., Mulcahy, L. S., Johnson, D. L., Barrett, R. W., Jolliffe, L. K., and Dower, W. J. (1996) Small peptides as potent mimetics of the protein hormone erythropoietin Science 273, 458-464
45. Zhao, P., Grabinski, T., Gao, C., Skinner, R. S., Giambernardi, T., Su, Y., Hudson, E., Resau, J., Gross, M., Vande Woude, G. F., Hay, R., and Cao, B. (2007) Identification of a met-binding peptide from a phage display library Clin. Cancer Res. 13, 6049-6055
46. Iuliano, R., Raso, C., Quintiero, A., Le Pera, I. L., Pichiorri, F., Palumbo, T., Palmieri, D., Pattarozzi, A., Florio, T., Viglietto, G., Trapasso, F., Croce, C. M., and Fusco, A. (2009) The eighth fibronectin type III domain of protein tyrosine phosphatase receptor J influences the formation of protein complexes and cell localization J. Biochem. 145, 377-385
47. Schroädinger, L.L.C., New York, NY (2010); www.schrodinger.com
48. Alcaro, S., Gasparrini, F., Incani, O., Mecucci, S., Misiti, D., Pierini, M., and Villani, C. (2000) A quasi-flexible automatic docking processing for studying stereoselective recognition mechanisms. Part I. Protocol validation J. Comput. Chem. 21, 515-530
49. Alcaro, S., Gasparrini, F., Incani, O., Caglioti, L., Pierini, M., and Villani, C. (2007) Quasi flexible automatic docking processing for studying stereoselective recognition mechanisms, Part 2: Prediction of Î"Î"G of complexation and 1H-NMR NOE correlation J. Comput. Chem. 28, 1119-1128